Viewing Study NCT06238635


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-06-04 @ 8:00 PM
Study NCT ID: NCT06238635
Status: RECRUITING
Last Update Posted: 2025-10-29
First Post: 2024-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dostarlimab and Cobolimab in Advanced Cervical Cancer
Sponsor: Meghan Shea
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
None Advanced Cervical Carcinoma View
None Metastatic Cervical Cancer View
None Metastatic Cervical Carcinoma View
None Recurrent Cervical Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cervical Cancer View
None Advanced Cervical Cancer View
None Advanced Cervical Carcinoma View
None Metastatic Cervical Cancer View
None Metastatic Cervical Carcinoma View
None Recurrent Cervical Cancer View
None Recurrent Cervical Carcinoma View